
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Morgan Stanley typically reports before market open, meaning Day 0 captures the first full trading session reaction to results, while Day +1 reflects follow-through momentum.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-07-15 | +$0.88 (+0.39%) | $11.03 (4.84%) | -$10.18 (-4.45%) | $12.44 (5.44%) |
| 2026-04-15 | +$8.28 (+4.52%) | $6.67 (3.64%) | -$4.30 (-2.24%) | $5.84 (3.05%) |
| 2026-01-15 | +$10.45 (+5.78%) | $11.16 (6.17%) | -$2.14 (-1.12%) | $3.68 (1.92%) |
| 2025-10-15 | +$7.31 (+4.71%) | $5.13 (3.30%) | -$2.63 (-1.62%) | $5.78 (3.55%) |
| 2025-07-16 | -$1.80 (-1.27%) | $4.73 (3.34%) | +$1.11 (+0.79%) | $2.56 (1.83%) |
| 2025-04-11 | +$1.54 (+1.44%) | $6.31 (5.93%) | +$0.99 (+0.92%) | $2.95 (2.73%) |
| 2025-01-16 | +$5.26 (+4.03%) | $4.25 (3.26%) | +$2.06 (+1.52%) | $3.55 (2.61%) |
| 2024-10-16 | +$7.29 (+6.50%) | $4.95 (4.41%) | -$0.07 (-0.06%) | $1.63 (1.36%) |
| Avg Abs Move | 3.58% | 4.36% | 1.59% | 2.81% |
Morgan Stanley's post-earnings price behavior shows significant volatility on announcement day, with an average absolute Day 0 move of 3.58% and intraday range of 4.36%. The direction has been predominantly positive, with six of the past eight earnings days closing higher.
The most dramatic reactions occurred in recent quarters: January 2026 saw a +5.78% Day 0 surge, April 2026 jumped +4.52%, and Q3 2025 rallied +4.71%—all following strong earnings beats. However, July 2026 proved an exception, with the stock gaining only +0.39% on Day 0 despite beating estimates, then declining -4.45% on Day +1, suggesting profit-taking after the run to all-time highs.
Day +1 follow-through is more muted, averaging 1.59% in absolute terms with a 2.81% range, indicating most of the price discovery happens in the initial session. Investors should expect meaningful volatility on Wednesday, with historical patterns suggesting a potential move in the 3-5% range based on the strength of the results and guidance.
| Metric | Value |
|---|---|
| Expiration Date | 10/16/26 (DTE 3) |
| Expected Move | $6.16 (3.30%) |
| Expected Range | $180.48 to $192.80 |
| Implied Volatility | 54.57% |
The options market is pricing an expected move of 3.30% ($6.16) for this earnings release, which aligns closely with Morgan Stanley's historical Day 0 average move of 3.58%. This suggests options traders are anticipating a typical-sized reaction rather than an outsized move, despite the uncertainty reflected in the wide range of analyst estimates.
Analysts maintain a moderately bullish stance on Morgan Stanley with an average recommendation of 3.74 (between Hold and Buy) and a mean price target of $226.67, implying 21.4% upside from the current price of $186.64. The consensus includes 10 Strong Buy ratings, 2 Moderate Buys, 14 Holds, and 1 Strong Sell among 27 analysts covering the stock.
Sentiment has deteriorated over the past month, with the average recommendation declining from 3.92 to 3.74. This shift reflects two analysts downgrading from Strong Buy to Hold, suggesting growing caution about near-term prospects. The deterioration coincides with the stock's pullback from its July highs and the pattern of downward estimate revisions heading into this report.
The price target range is wide, spanning from a low of $195.00 to a high of $270.00, reflecting divergent views on the company's trajectory. The mean target of $226.67 sits well above the current trading level, indicating that even with recent sentiment deterioration, analysts see significant value at current prices—though the 21.4% implied upside is contingent on the company delivering on earnings expectations and demonstrating sustainable momentum in its wealth management franchise.
Morgan Stanley enters earnings in a deteriorating technical position, with the Barchart Technical Opinion showing a 56% Sell signal—a significant shift from the 24% Buy signal just one month ago and the 40% Sell reading last week. This rapid deterioration reflects the stock's sustained weakness since peaking at $228.55 in mid-July.
The stock is trading below all key moving averages, a bearish configuration that signals broad-based selling pressure:
Trend Characteristics: The signal strength is classified as "Soft" but "Strengthening," indicating the bearish momentum is building rather than exhausting itself heading into the earnings release.
At $186.64, Morgan Stanley is trading below its 5-day ($188.77), 10-day ($189.14), 20-day ($194.18), 50-day ($206.43), 100-day ($210.54), and 200-day ($194.29) moving averages. The 50-day and 100-day averages at $206.43 and $210.54 represent significant overhead resistance levels, while the 200-day at $194.29 marks the first meaningful resistance zone.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $188.77 | 50-Day MA | $206.43 |
| 10-Day MA | $189.14 | 100-Day MA | $210.54 |
| 20-Day MA | $194.18 | 200-Day MA | $194.29 |
The technical setup is cautionary heading into earnings, with the stock in a clear downtrend and no nearby support from moving averages. The 100% Sell short-term signal suggests any disappointment could trigger accelerated selling, while a strong beat would need to be substantial enough to reverse the negative momentum and reclaim the 200-day moving average at $194.29. The deteriorating technical picture raises the bar for what constitutes a "good" earnings report, as investors will likely demand not just a beat but also compelling guidance to shift the trend.